HeartsciencesHSCS
13F holders, Q1 2025 (March 31)5holders +2
2new positions
0sold out
$2.82avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Heartsciences Inc. (HSCS) in their 13F filings, up 2 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were Astoria Strategic Wealth, Inc. ($53K), UBS Group AG ($7K) and Tower Research Capital LLC (TRC) ($4K).
- Company
- Heartsciences Inc.
- CUSIP
- 42254E302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $55K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 22,081 shares bought, net +22,081 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Astoria Strategic Wealth, Inc. | 0.02% | New | 18,927 | $53K |
| UBS Group AG | 0.00% | Add +101.2% | 2,625 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1283.0% | 1,383 | $4K |
| Osaic Holdings, Inc. | 0.00% | New | 550 | $2K |
| Bank of America Corp. | 0.00% | Add +12.5% | 9 | $25 |
"% of holder's portfolio" is HSCS's weight in each manager's 13F, not the share of Heartsciences Inc. the manager owns.